Search the Newsreel

Perdoceo Education (PRDO) Matches Q2 Earnings Estimates

Nerdy Inc. (NRDY) Reports Q2 Loss, Beats Revenue Estimates

Higher H1 profit, big buybacks at NerdWallet (NASDAQ: NRDS)

NerdWallet (NASDAQ: NRDS) reported a significant increase in first-half 2026 net income to $24.7 million, up from $8.4 million the previous year, with operating cash flow surging to $76.9 million. This strong performance supported a $17.2 million acquisition and $89.2 million in share repurchases. …

NerdWallet, Inc. (NRDS) Releases Q2 2026 Earnings: Revenue Up 5.6% as Profitability Softens

PERDOCEO EDUCATION ($PRDO) Releases Q2 2026 Earnings

In the second quarter of 2026, Perdoceo Education reported higher revenue of US$213.36 million and net income of US$47.97 million, raised its quarterly dividend to US$0.17 per share, and issued updated earnings guidance for 2026. The combination of stronger profitability, a 13.3% dividend increase, …

NerdWallet (Nasdaq: NRDS) details Q2 2026 results and raises 2026 outlook targets

NerdWallet (Nasdaq: NRDS) reported Q2 2026 revenue of $197.3 million, a 6% increase year-over-year, with GAAP net income of $4.3 million. The company's consumer revenue grew by 8%, driven by personal loans and deposit accounts, while SMB revenue declined by 11% due to organic …

Three New Hires Receive Stock Awards With Up to 4-Year Vesting

NewAmsterdam Pharma has granted inducement equity awards to three new non-executive hires, consisting of 28,000 share options and 8,200 restricted stock units (RSUs). The share options have an exercise price of $27.79 and vest over four years, while the RSUs vest over three years …

Perdoceo Education (NASDAQ: PRDO) lifts profit, hikes dividend and boosts 2026 EPS outlook

Perdoceo Education Corporation Reports Second Quarter and Year to Date 2026 Results

Increases quarterly dividend by 13.3% to $0.17 per share SCHAUMBURG, Ill., August 06, 2026--(BUSINESS WIRE)--Perdoceo Education Corporation (NASDAQ: PRDO), a provider of postsecondary education programs through its academic institutions, today reported operating and financial results for the second quarter and year to date ended …

Nerdy Inc. Revises Earnings Guidance for the Year 2026

Earnings Flash (PRDO) Perdoceo Education Corporation Posts Q2 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.80

Perdoceo Education Corporation (PRDO) announced its Q2 adjusted EPS at $0.80 per share, which met FactSet's estimate. The company also reported Q2 revenue of $213.4 million, slightly exceeding FactSet's estimate of $212.5 million. Additionally, Perdoceo Education Corporation expects its Q3 adjusted EPS to be …

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma announced that its Compensation Committee approved inducement grants under Nasdaq Listing Rule 5635(c)(4) for new hires. These grants include share options for 28,000 ordinary shares and restricted stock units for 8,200 ordinary shares, both intended to incentivize new non-executive employees to join …

Nerdy Inc (NRDY) Earnings Forecast: Future EPS & Revenue Growth Estimates

Nerdy Inc (NRDY) has an earnings forecast score of 7.00, placing it 302nd in the Software & IT Services industry. Analysts have set an average price target of $1.62 with a "Buy" rating, projecting a 92.90% upside. The company's expected revenue for the next …

Nerdy (NYSE: NRDY) cuts losses, exits school business and faces NYSE risk

Nerdy (NYSE: NRDY) reported a narrowed Q2 2026 net loss of $6.9 million, down from $12.0 million year-over-year, driven by improved gross margins and reduced operating expenses. The company strategically exited its First Tutors business and plans to wind down Varsity Tutors for Schools, …

(NAMSW) Volatility Zones as Tactical Triggers

This article provides an AI-generated analysis of Newamsterdam Pharma Company N.v. Warrant (NASDAQ: NAMSW), focusing on volatility zones as tactical triggers for trading. It outlines institutional trading strategies tailored to different risk profiles, including position trading, momentum breakout, and risk hedging, along with multi-timeframe …

Gerdau S.A. Stock 12‑Month Price Target Raised to $5.32, Implies 4% Upside

Analysts have raised the 12-month average price target for Gerdau S.A. stock (GGBR3) from $5.25 to $5.32, representing a potential 4% upside from its Aug. 5 closing price. The consensus rating remains a "Buy" from 11 analysts, with 9 recommending Buy and 2 recommending …

Gerdau S.A. (GGB) stock price, news, quote and history

This article provides a comprehensive overview of Gerdau S.A. (GGB) stock, including its current price, market performance, and company profile. It details key financial metrics, earnings trends, analyst insights, and compares GGB with similar companies in the steel industry. The article is current as …

Gerdau S.A. (NYSE:GGB) Raises Dividend to $0.04 Per Share

Gerdau S.A. (NYSE:GGB) announced a 24.1% increase in its quarterly dividend to $0.0448 per share, payable on September 18th to shareholders of record by August 21st. The annualized dividend is approximately $0.11 per share, yielding 3.5%, and is well-covered by earnings with a payout …

FMR LLC and Abigail Johnson report 10.3M-share Pharma Company NV (NAMS) stake

FMR LLC and Abigail P. Johnson have reported a significant ownership stake in NewAmsterdam Pharma Co N.V. (NAMS), collectively holding 10,339,663 shares of common stock, which represents 8.8% of the class as of June 30, 2026. FMR LLC has sole voting power over 10,329,760 …

Nerdy Inc. Provides Earnings Guidance for the Third Quarter of 2026

NerdWallet, Inc. (NRDS) Q2 Earnings Miss Estimates

NerdWallet revenue rises 6% as net income falls 48% in Q2

Perdoceo Education (NASDAQ:PRDO) Issues FY 2026 Earnings Guidance

[10-Q] PERDOCEO EDUCATION Corp Quarterly Earnings Report

NewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary

NewAmsterdam Pharma Co N.V. (NAMS) reported a significant decline in Q2 2026 revenue to $3.7M from $19.1M year-over-year, alongside a widened net loss of $64.1M, or $0.52 diluted EPS. This downturn is attributed to lower partner-derived receipts after a one-time 2025 development installment and …

InterDigital Currently Up Nine Consecutive Days, On Track for Longest Winning Streak Since May 2025 -- Data Talk

InterDigital (IDCC) has seen its stock price increase for nine consecutive days, putting it on track for its longest winning streak since May 2025. Over this nine-day period, the stock has gained 4.1%, outperforming the S&P 500's 1.7% decline. The company's average daily volume …

Gerdau Q2 2026 slides: EBITDA surges 16% on North America strength

Brazilian steelmaker Gerdau reported a strong second quarter in 2026, with adjusted EBITDA surging 16% sequentially to R$ 3.4 billion, primarily driven by robust demand in North America and improved operational efficiency. Despite strong performance, shares saw a modest decline as investors considered future …

Metalurgica Gerdau SA (BSP:GOAU3) (Q2 2026) Earnings Call Highlights: Record EBITDA and ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Metalurgica Gerdau SA (BSP:GOAU3) reported its best consolidated EBITDA since Q3 2023, with a 15% …

Gerdau Files Mid‑Year 2026 Interim Financials with U.S. SEC

Gerdau S.A. has filed its unaudited condensed consolidated interim financial statements as of June 30, 2026, with the U.S. SEC, providing updated financial visibility for U.S. investors. The filing shows stable total assets at R$81.97 billion, largely consistent with year-end 2025, and a stable …

NewAmsterdam Pharma (NASDAQ:NAMS) Announces Quarterly Earnings Results

IDCC (IDCC) insider Rajesh Pankaj plans NASDAQ sale of 1,500 shares

Rajesh Pankaj, an insider at InterDigital, Inc. (IDCC), has filed a Form 144 to announce the planned sale of 1,500 common shares on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The aggregate market value of these shares is approximately $487,320.00, and …

PRDO - 5/8/26 - Perdoceo Education Corporation

Perdoceo Education (PRDO) is currently trading at US$33.03, significantly undervalued by 64% compared to its intrinsic fair value of US$91.64, based on a discounted free cash flow model. The company exhibits strong financials with a 16.4% return on invested capital, 24.3% operating margin, and …

Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

NewAmsterdam Pharma provided a corporate update and reported its second quarter financial results. The company highlighted recent achievements and ongoing clinical trials, offering insights into its financial position and future strategic directions. This update serves to inform stakeholders about the company's progress and performance.

Gerdau S.A. 2026 Q2 - Results - Earnings Call Presentation (NYSE:GGB) 2026-08-05

This article presents the Q2 2026 earnings call presentation for Gerdau S.A. (NYSE: GGB). The company reported an EPS of $0.14, missing estimates by $0.01, and revenue of $3.48 billion, exceeding expectations by $61.56 million and representing an 11.18% year-over-year increase. The accompanying slide …

Earnings call transcript: Gerdau posts huge Q2 2026 beat as North America shines

NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears

NewAmsterdam Pharma outlined its strategy for obicetrapib, emphasizing the ongoing PREVAIL cardiovascular outcomes trial and commercial preparations for a potential European launch. The company expects to reach its interim event target for the PREVAIL trial by year-end, with an independent review in Q1 2027. …